COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Commentary: SARS-CoV-2 vaccines and cancer patients

(2021) C. Corti et al.   ANNALS OF ONCOLOGY

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

(2021) Tiziano Barbui et al.   LEUKEMIA

Looking beyond COVID-19 vaccine phase 3 trials

(2021) Jerome H. Kim et al.   NATURE MEDICINE

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

(2021) Akshay Sharma et al.   Lancet Haematology

Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of Coronavirus Disease (COVID-19) Vaccination

(2021) Christine E. Edmonds et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate

(2021) M.C. Garassino et al.   ANNALS OF ONCOLOGY

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

(2021) Timothy A Yap et al.   LANCET ONCOLOGY

COVID-19 vaccination: the VOICE for patients with cancer

(2021) Astrid A. M. van der Veldt et al.   NATURE MEDICINE

Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US

(2021) Monita Karmakar et al.   JAMA Network Open

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

(2020) Nicole M Kuderer et al.   LANCET

Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials

(2020) Joseph M. Unger et al.   JAMA Network Open

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

(2020) Denis Y Logunov et al.   LANCET

Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studies

(2020) Aakash Desai et al.   CANCER

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

(2020) Antoni Ribas et al.   Cancer Discovery

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials

(2020) Mark E. Fleury et al.   JAMA Oncology

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

(2020) Yanjun Zhang et al.   LANCET INFECTIOUS DISEASES

Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations

(2017) Mariana Castells   Frontiers in Immunology

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles

(2016) Bhumsuk Keam et al.   CANCER

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

(2013) Lorry G. Rubin et al.   CLINICAL INFECTIOUS DISEASES